STAT Plus: Agios drug demonstrates strong response in patients with inherited blood disorder
RUBY WALLAU FOR STAT
The company's push into thalassemia as well as sickle cell disease could transform the medication into a commercial blockbuster.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario